World Economic Forum, Lord O’Neill Call For More Effort To Create New Antibiotics, Fight Antimicrobial Resistance

CIDRAP News: World Economic Forum seeks ‘pull’ incentives for new antibiotics
“In a new report, the World Economic Forum (WEF) throws its weight behind the push for ‘pull’ incentives for the development of new antibiotics, which aim to ensure that drugs that reach the market will be profitable. The WEF says it’s time for governments and pharmaceutical companies to collaborate to make ‘tangible, incremental progress’ on designing pull incentives to demonstrate the viability of the approach. The report was issued Jun 22 in collaboration with the Wellcome Trust…” (Roos, 6/26).

Financial Times: Pharma sector failing to tackle superbugs, says O’Neill
“The pharmaceutical industry has failed to seriously commit to the fight against drug-resistant superbugs, Jim O’Neill said on Tuesday, as he called for a new tax on drug sales. Lord O’Neill, the former chief economist of Goldman Sachs, led a U.K. government review of antimicrobial resistance in 2016. … Writing in the Journal of Applied Microbiology, Lord O’Neill gave a downbeat assessment of progress in implementing the recommendations of his 2016 report…” (Cookson, 6/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.